US20110203923A1 - Sensing apparatus and process - Google Patents

Sensing apparatus and process Download PDF

Info

Publication number
US20110203923A1
US20110203923A1 US12/862,690 US86269010A US2011203923A1 US 20110203923 A1 US20110203923 A1 US 20110203923A1 US 86269010 A US86269010 A US 86269010A US 2011203923 A1 US2011203923 A1 US 2011203923A1
Authority
US
United States
Prior art keywords
substrate
electrical connection
beads
sensing apparatus
sensor module
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/862,690
Inventor
Ronald J. Lebel
Rajiv Shah
Yanan Zhang
Edward Chernoff
Rudolph A. Montalvo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Minimed Inc
Original Assignee
Medtronic Minimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Minimed Inc filed Critical Medtronic Minimed Inc
Priority to US12/862,690 priority Critical patent/US20110203923A1/en
Publication of US20110203923A1 publication Critical patent/US20110203923A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1486Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
    • A61B5/14865Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1468Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
    • A61B5/1473Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49002Electrical device making
    • Y10T29/49117Conductor or circuit manufacturing
    • Y10T29/49204Contact or terminal manufacturing

Definitions

  • Embodiments of the present invention claim priority from a U.S. Provisional Application entitled “Sensing Apparatus and process,” Ser. No. 60/318,060 filed Sep. 7, 2001, the contents of which are incorporated by reference herein.
  • the present invention relates to the field of sensor technology and, in particular, to implantable, in-vivo sensing systems used for sensing a variety of parameters, including physiological parameters.
  • biosensors and microelectronics have resulted in the availability of portable diagnostic medical equipment that has improved the quality of life for countless people.
  • Some medical conditions have been amenable to automated, implantable sensing. For example, thousands of people with heart conditions have had pacemakers or defibrillators implanted into their bodies that utilize sensors for monitoring the oxygen content of their blood. . Ideally, these sensors should be able to determine whether, for example, a person's heart is running very efficiently at a high heart rate or whether a person's heart has entered defibrillation. In order to effectively make this determination, an accurate sensor must be employed. Unfortunately, oxygen sensors implanted into the body have, thus far, typically required frequent and periodic checking and recalibration. In fact, one of the “holy grails” of the pacemaker industry has been an accurate, no drift, no calibration oxygen sensor. Up until now, such a sensor has been unavailable.
  • An ideal solution to the diagnostic requirements of those with disease or disability, absent an outright cure, is a sensing apparatus that may be implanted into the body and that may remain in the body for extended periods of time without the need to reset or recalibrate the sensor. Regardless of the particular application for such a sensor system, in order to effect such a system, the associated sensor must remain accurate, exhibit low drift and require no recalibration for extended periods of time.
  • an ideal implantable sensing apparatus would provide for a sensing apparatus that may be inserted into a vein, artery or other part of a body while being unobtrusive, easy to insert and remove, yet accurate and reliable.
  • Embodiments of the present invention provides such a system.
  • Embodiments of the present invention relate to a sensing apparatus.
  • a sensing apparatus includes a cable having a first end and a second end, a connector residing at the first end of the cable and a sensor module residing at the second end of the cable.
  • the cable, the connector and the sensor module may be unidiametrical.
  • the cable may comprise a core, a conductive element wrapped around the core, and a first tubing covering the core and the conductive element.
  • the core may be polyester.
  • the conductive element may be a ribbon cable.
  • the conductive element may include wires.
  • the wires may be platinum.
  • the wires may be welded to the connector and the sensor module. Alternatively, the wires may be crimped to the connector.
  • the first tubing of the cable may be radio opaque.
  • a second tubing may cover the first tubing.
  • a window may be cut into the second tubing.
  • the sensor module may have a first end and a second end. Beads may encapsulate the first end and the second end.
  • the sensor module may also have a spacing element. A height of the spacing element may be greater than a height of the beads.
  • the sensing apparatus may also include an enzyme.
  • the enzyme may be glucose oxidase or human serum albumin.
  • the enzyme may be a protein matrix.
  • the enzyme may be hydrated.
  • a method of making a sensing apparatus may comprise obtaining a connector; obtaining a cable; obtaining a sensor module; attaching a first end of the cable to the connector; and attaching a second end of the cable to the sensor module.
  • the method may further include forming beads over ends of the sensor module; inserting a spacing element between the beads; covering the sensor module with a tubing of the cable; cutting a window in the tubing of the cable; and inserting an enzyme in the sensor module.
  • FIG. 1 is a perspective view of a generalized sensing apparatus configuration according to an embodiment of the present invention.
  • FIG. 2A is a perspective view of an electrode side of a generalized sensor module configuration according to an embodiment of the present invention.
  • FIG. 2B is a perspective view of an electronics side of a generalized sensor module configuration according to an embodiment of the present invention.
  • FIG. 3A is a perspective view of an electrode side of a generalized sensor module configuration with encapsulated ends according to an embodiment of the present invention.
  • FIG. 3B is a perspective view of an electronics side of a generalized sensor module configuration with encapsulated ends according to an embodiment of the present invention.
  • FIG. 4 is a perspective view of a sensor module configuration wherein two sensor modules are connected together in a “daisy-chain” fashion according to an embodiment of the present invention.
  • FIG. 5 is a perspective view of a sensor module with spacers according to an embodiment of the present invention.
  • FIG. 6A is a perspective view of a generalized sensor lead according to an embodiment of the present invention.
  • FIG. 6B is a perspective view of a conductor element according to an embodiment of the present invention.
  • FIG. 7 is a process for making a sensing apparatus according to an embodiment of the present invention.
  • FIG. 8 is a side showing a window cut into an outer tubing of the sensor. lead according to an embodiment of the present invention.
  • FIG. 9 is a process for removing or replacing a sensing apparatus according to an embodiment of the present invention.
  • Embodiments of the present invention comprise a sensing apparatus including, without limitation, a sensor module, a sensor lead and a connector.
  • the sensor module may comprise, without limitation, an enzyme and one or more spacers.
  • the lead may comprise, without limitation, a core, a conductor, a first tubing and a second tubing.
  • each element of the sensing apparatus may be modified separately or in conjunction with another element according to the application or environment in which sensing apparatus is used.
  • the sensing apparatus may be seen as .a plurality of modular, individual elements, each of which may be modified and combined with one another to provide a sensing apparatus that may be used in a variety of applications, in a variety of environments, and implanted in a variety of locations.
  • FIG. 1 shows a generalized sensing apparatus configuration according to an embodiment of the present invention.
  • a sensing apparatus 10 includes a sensor lead 12 , a first end 14 comprising a connector 16 and a second end 18 comprising a sensor module 20 . Molded onto each end of the sensor module 20 are beads 22 .
  • An ogive, or bullet shaped, tip 24 attaches to a bead 22 that is opposite the sensor lead 12 such that the entire assembly is streamlined in a fluidic environment, such as a bloodstream.
  • the sensor lead 12 comprises tubing that attaches to the ogive tip 24 .
  • the entire sensing apparatus 10 may be placed in a vein or other area within a human body using a process according to an embodiment of the present invention to be discussed below.
  • the connector 16 may be a male, female or other type connector.
  • the connector 16 may provide for multiple conductive paths, thereby accommodating a variety of sensor lead 12 configurations.
  • the connector 16 may be made from a variety of materials.
  • the connector 16 may be made from any material that is electrically conductive yet chemically inert.
  • FIGS. 2A and 2B show a generalized sensor configuration according to an embodiment of the present invention.
  • a sensor module 20 may include a substrate 30 having a sensing element side 32 and an electronics side 34 .
  • the substrate 30 may be made from ceramic or other materials.
  • electrodes 36 may be deposited onto the sensing element side 32 of the substrate 30 .
  • the electrodes 36 may interface with a sensing element (not shown) which will be described below.
  • the electronics side 34 of the substrate 30 may include a lid 38 that covers a variety of electronics, such as, for example, an integrated circuit 40 and a capacitor 42 .
  • the electronics side 34 of the substrate 30 may also include welding pads 44 to which wire leads may be welded as well as other types of pads and traces common to electronic circuitry.
  • the electrodes 36 and the electronics on the electronics side 34 of the substrate 30 provide the basis for electrochemical measurement.
  • the sensor module 20 may be utilized for oxygen sensing.
  • the sensor module is not limited to this application and may also be utilized in other applications such as, for example, for ion, neurotransmitter or nitric oxide sensing.
  • FIGS. 3A and 3B show further details of a generalized sensor configuration according to an embodiment of the present invention.
  • a portion of the electrode pattern may be encapsulated by the beads 22 .
  • beads 22 may be molded over the ends of the substrate 30 such that the welding pads 44 and any wires welded to the welding pads 44 are encapsulated within the beads 22 .
  • the beads 22 may also encapsulate a core of the sensor lead 12 , thereby giving the core an anchor.
  • the beads 22 may be formed over the ends of the substrate 30 using a mold.
  • the substrate 30 may be placed into the mold and the ends of the substrate 30 subsequently covered with an epoxy or other encapsulating material.
  • FIG. 4 shows a sensor configuration wherein two sensor modules 20 are connected together in a “daisy-chain” fashion.
  • the welding pads 44 may be straight-through pads, such that electrical continuity exists between corresponding welding pads 44 on opposite sides of each sensor module 20 .
  • the sensing modules 20 may be individually addressed using a two-wire line and unique addresses.
  • FIG. 5 shows a sensor module with spacers according to an embodiment of the present invention.
  • a first spacing element 50 may be placed over the electrodes 36 , fitting into a recess between the beads 22 .
  • the first spacing element 50 may be thought of as a spacer shim because it has the function of maintaining a certain distance or space between the electrodes 36 and an enzyme which may eventually be placed within the sensor module 20 .
  • the floor 52 of the first spacing element 50 may be such that it allows the passage of oxygen. If, for example, the first spacing element is made from silicone or polydimethylsiloxane, the floor 52 of the first spacing element 50 will pass oxygen but will not pass other compounds found in the bloodstream, such as glucose.
  • An enzyme and space may be used to fine tune sensor performance.
  • the size and configuration of the enzyme and spacer may be modified to effect of variety of sensing characteristics.
  • the enzyme and spacer size and configuration may be modified to improve dynamic range, reduce noise due to oxygen transients, and increase sensing apparatus lifetime.
  • the configuration of the enzyme and spacer may be driven by a variety of factors including, without limitation, the need to measure a physiological parameter, such as, for example, blood glucose, and the need to keep membranes of the sensor module 20 in compression during the lifetime of the device.
  • a second spacing element 54 fits within the first spacing element 50 and provides support for a window that may be cut into tubing that covers the sensor module 20 and attaches to the ogive tip 24 . After the window has been cut, as will be explained below, the second spacing element 54 may be discarded and an enzyme or other sensing catalyst may be disposed in its place.
  • An outer tubing of the sensor lead 12 may be pulled over the first spacing element 50 .
  • the outer diameter of the first spacing element 50 may be such that it is greater than the inner diameter of the outer tubing of the sensor lead 12 .
  • the first spacing element 50 may be forced against the electrodes 36 on the substrate 30 by the contraction force of the outer tubing.
  • the spacing elements may be made from the same mold used to form the beads 22 . If the same mold that was used to form the beads 22 is used to form the spacing elements 50 , 54 , the spacing elements 50 , 54 will form a precise fit with the beads 22 .
  • the spacing elements 50 , 54 may be made from silicon or other suitable material.
  • the height of the first spacing element 50 may extend beyond the height of the beads 22 .
  • any compression upon the first spacing element 50 such as that that might be applied when the outer tubing of the sensor lead 12 is slipped over the sensor module 20 , tends to stabilize the dimensions of the elements of the apparatus, such as membranes that may exist above the electrodes 36 , that may change through chemical reaction.
  • FIG. 6A shows a generalized sensor lead 12 according to an embodiment of the present invention.
  • the core 60 may be a material such as, for example, polyester or other material, or a commercially available material such as, for example, DACRON OR KEVLAR, that provides shock absorption and strength to the sensor lead 12 .
  • a polyester core may provide as much as 18-20 lbs. of tensile strength to the sensor lead 20 .
  • the core 60 limits sensor lead 12 elongation.
  • the sensing apparatus 10 may pull on the sensor lead 12 without fear of excessively stretching it or breaking it.
  • a doctor or other medical professional who needs to remove the sensing apparatus 10 from the vein may pull on the sensor lead 12 without fear of excessively stretching it or breaking it.
  • Various factors may influence the size of the core 60 and the material used for the core 60 such as, for example, the overall diameter, device stiffness, and sensor lead 12 attachment scheme.
  • the conductive element 62 may be a flat cable or ribbon cable having multiple conductor wires.
  • the conductive element 62 may also be a laminate structure conducive to being wrapped around the core 60 with a pitch in between the windings such that the conductive element 62 has enough flexibility to move with the core 60 if the core 60 is stretched.
  • the helical nature of the winding also contributes to the flexibility of the conductive element 62 if the core 60 is stretched or otherwise moved.
  • the conductive element 62 may include only a few wires, such as, for example, three wires or four wires.
  • the conductive element 62 may include a larger number of wires, such as, for example, five wires, ten wires or more.
  • the size of the conductive element 62 , the number of wires in the conductive element 62 , and the materials used as the conductive element 62 may be influenced by a variety of factors including, without limitation, sensing apparatus application and signal transmission requirements.
  • the size of the conductive element 62 , the number of wires in the conductive element 62 , and the materials used as the conductive element 62 may be chosen depending on whether the sensing apparatus is used in digital or analog applications or depending on a particular communications protocol.
  • the strength of the conductive element 62 needed for a particular application may be a factor in determining wire size.
  • the wires used in the conductive element 62 may be, for example, platinum, iridium, MP35, gold or silver, or other conductive material.
  • a first tubing 64 may be slid around the core 60 wrapped with the conductive element 60 .
  • the first tubing 64 may be made from a radio opaque material such as silicone or may be made from other materials such as, for example, radio opaque polyurethane.
  • the size and dimensions of the first tubing 64 and the materials used for the first tubing 64 may be influenced by a variety of factors including, without limitation, the overall stiffness requirements of the sensor lead 12 according to the application of the sensing apparatus 10 .
  • a second tubing 66 may be slid around the first tubing 64 .
  • the second tubing 66 may be made from silicone or other material.
  • the second tubing 66 may be used to provide oxygen transport and mechanical compression.
  • the surface of the second tubing 66 may be treated for biocompatibility, lubricity and stiffness.
  • the conductive element 62 may be a flat cable having four wires 68 as shown in FIG. 6B .
  • the wires 68 may be platinum or another type of conductor, such as, for example, a noble metal.
  • the diameter of each wire 68 may be as thin as one one-thousandth of an inch or thinner and the entire cable may be molded with TEFLON or another insulator such that the wires are insulated from one another. Because much of the strength of the sensor lead 12 may be derived from the core 60 , the wires themselves need not be chosen for strength. Thus, the wires need a diameter only as large as necessary to carry the currents being generated by the devices to which the sensor lead 12 is attached.
  • the currents generated may be on the order of hundreds of nanoamps or tens of microamps.
  • the type of wire used in the sensor lead 12 may be chosen accordingly.
  • the wires may be chosen such that they can accommodate a current of a few milliamps, a typical value for heart stimulating pulses used in pacemakers.
  • a metal such as platinum may be used as the wire.
  • Platinum although very fragile at the small diameters required for carrying the electrical currents just mentioned, such as, for example, one one-thousandth of an inch, is chemically inert and corrosion resistant and, thus, desirable in a fluidic environment, such as blood.
  • the wires are so thin, they may be generally less intrusive to the environment in which they are placed than larger diameter wires typically used in an in-vivo application.
  • a thin, fragile wire may be used where, traditionally, larger diameter, strong wires have been used.
  • a wire made from a metal such as platinum may be employed.
  • the cable may be stripped and the wires connected together in groups of two. Once connected together, the wires may be viewed as two wires having two strands each. Thus, the wires are redundant and should one break, another is available to maintain electrical continuity. One of the wire pairs may then be crimped and welded to the connector 16 and the other wire pair may be spot welded to the wire pads 44 on the sensor module 20
  • a completed sensor lead 12 may be labeled for identification or other purposes.
  • a variety of labeling materials may be used for labeling. According to one embodiment of the present invention, any labeling material may be used so long as the material chosen remains visible after sterilization of the sensing apparatus 10 .
  • the label may be placed in a variety of positions on the sensor lead 12 .
  • the label may be placed on the outer surface of the first tubing 64 in between the first tubing 64 and the second tubing 66 using an green-colored, epoxy based ink that is biocompatible and that does not leach toxic materials into or out of the sensor lead 12 .
  • FIG. 7 shows a process for making a sensing apparatus according to an embodiment of the present invention.
  • the connector 16 , the sensor lead 12 and the sensor module 20 are obtained.
  • the wires in the conductive element of the sensor lead 12 are attached to the pads 44 on the substrate 30 of the sensor module 20 and to the connector 16
  • the wires in the conductive element may be welded or otherwise attached to the pads 44 and crimped or otherwise attached to the connector.
  • beads 22 are formed over the ends of the substrate 30 such that the welding pads, a portion of the electrodes 36 and the core 60 are encapsulated within the beads 22 .
  • an ogive tip 24 may be glued or otherwise attached to a bead 22 opposite the sensor lead 12 .
  • spacing elements may be inserted in between the beads 22 .
  • the spacers may comprise a first spacing element 50 and a second spacing element 54
  • an outer tubing of the sensor lead 12 may be pulled over the sensor module 20 and attached to the ogive tip 24 attached to the bead 22 opposite the sensor lead 12 .
  • a window may be cut in the outer tubing of the sensor lead 12 over the second spacing element 54 .
  • the window may be cut and placed in a manner suitable for the application of the sensing apparatus 10 and such that the sensitivity of the apparatus is advantageous.
  • the window may be cut with a particular width and at such a place on the outer tubing of the sensor lead 12 such that oxygen influx into the enzyme is aided.
  • a typical window width may be five thousandths of an inch, or may be ten to twenty thousandths of an inch.
  • window depth may be anywhere from about four thousandths of an inch to ten thousandths of an inch.
  • the response time of the device may also be adjusted by the cut and placement of the window.
  • a window 94 cut into an outer tubing of the sensor lead 12 may be seen in FIG. 8 .
  • the second spacing element 54 may be removed at step 82 and the entire sensing apparatus 10 may be sterilized.
  • the sterilization step 84 may be implemented using a variety of sterilization techniques.
  • the entire sensing apparatus 10 (which may or may not include an enzyme, protein, or other physiological parameter sensor) may be put into an ethylene oxide (ETO) gas such that the ETO gas permeates all of the elements of the sensing apparatus 10 .
  • ETO ethylene oxide
  • an enzyme may be put in the place of the second spacing element 54 through the window at step 86 .
  • the enzyme may be any of a variety of enzymes that may be employed for sensing.
  • one or more proteins may be used as the enzyme.
  • a combination of glucose oxidase and human serum albumin may be used concurrently in a solid matrix form to form a sensor matrix protein (SMP).
  • SMP may be cross-linked together or glymerized using glutaraldehyde or other suitable chemical such that a three-dimensional structure is created.
  • the enzyme may be hydrated at step 88 such that it expands to form a tight fit and to fill the area left by the removal of the second spacing element 54 .
  • the enzyme may initially be in a slightly desiccated state when placed into the area vacated by the second spacing element 54 . Although such a desiccated state facilitates placement, space may exist between the enzyme and the surround area of the sensor module 20 .
  • the surrounding area and the enzyme may be hydrated with a sterile buffer, thereby swelling the enzyme and forming a compression fit with the first spacing element 50 .
  • any cavity left in surrounding area after the enzyme has been hydrated may be filled at step 90 with, for example, a hydrogel, such as, for example, methacrylate or other hydrophilic acrylic, that is permeable to the sterilant. Subsequently, the hydrogel may be polymerized using a UV polymerization process.
  • a hydrogel such as, for example, methacrylate or other hydrophilic acrylic
  • the window may be closed and the sensing apparatus 10 may be sterilized again in a manner that is not damaging to the enzyme.
  • a more dilute form of the glutaraldehyde may be used to sterilize the sensing apparatus 10 after the enzyme has been place in the first spacing element 50 .
  • the sensing apparatus 10 may then be used as necessary.
  • FIG. 9 shows a process for removing or replacing a sensing apparatus from a vein or artery.
  • the vein or artery may belong to a human being or other animal.
  • a connector 16 that has been implanted into a vein along with the rest of the sensing apparatus is found by locating it under the skin by touch and feel in the general area that the connector 16 should be residing.
  • an incision is made into the skin and the connector 16 may be brought out of the skin.
  • a tool with clamping fingers is placed over the connector 16 such that the fingers close onto the connector 16 and form a secure connection with the connector 16 .
  • a canula/introducer is then slid over the tool and the connector at step 106 into the vein at the location of the incision. Fabricating the connector 16 , the sensor lead 12 , and the sensor module 20 to be unidiametrical facilitates sliding the canula/introducer over them. While the canula/introducer remains in the vein, the tool, connector 16 , sensor lead 12 and sensor module 20 may be pulled through the canula/introducer at step 108 , thereby removing the sensing apparatus 10 from the vein.
  • a new sensing apparatus may be inserted into the vein. Once the new sensing apparatus is inserted into the vein, the canula/introducer may be removed at step 112 and the incision may be sewn up.

Abstract

A sensing apparatus with a connector, a sensor lead and a sensor module with a spacer placed over electrodes that have been deposited on a substrate. The spacer may have a space for receiving an enzyme. End portions of the sensor module may be encapsulated, such as with molded beads. A sensor lead may attach to the sensor module and may have an outer tubing that passes over the module and attaches to the beads at the end of the sensor module. The sensor lead may also attach to the connector such that the sensing apparatus may be electrically coupled to a pump, electronics or other devices. The sensing apparatus may be implanted into a vein or artery.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • Embodiments of the present invention claim priority from a U.S. Provisional Application entitled “Sensing Apparatus and process,” Ser. No. 60/318,060 filed Sep. 7, 2001, the contents of which are incorporated by reference herein.
  • BACKGROUND
  • 1. Field of the Invention
  • The present invention relates to the field of sensor technology and, in particular, to implantable, in-vivo sensing systems used for sensing a variety of parameters, including physiological parameters.
  • 2. Description of Related Art
  • The combination of biosensors and microelectronics has resulted in the availability of portable diagnostic medical equipment that has improved the quality of life for countless people. Many people suffering from disease or disability who, in the past, were forced to make routine visits to a hospital or doctor's office for diagnostic testing currently perform diagnostic testing on themselves in the comfort of their own homes using equipment with accuracy to rival laboratory equipment.
  • Nonetheless, challenges in the biosensing field have remained. For example, although many diabetics currently utilize diagnostic medical equipment in the comfort of their own homes, the vast majority of such devices still require diabetics to draw their own blood and inject their own insulin. Drawing blood typically requires pricking a finger. For someone who is diagnosed with diabetes at an early age, the number of self-induced finger pricks over the course of a lifetime could easily reach into the tens of thousands. In addition, the number of insulin injections may also reach into tens of thousands. Under any circumstances, drawing blood and injecting insulin thousands of times is overly invasive and inconvenient at best and most likely painful and emotionally debilitating.
  • Some medical conditions have been amenable to automated, implantable sensing. For example, thousands of people with heart conditions have had pacemakers or defibrillators implanted into their bodies that utilize sensors for monitoring the oxygen content of their blood. .Ideally, these sensors should be able to determine whether, for example, a person's heart is running very efficiently at a high heart rate or whether a person's heart has entered defibrillation. In order to effectively make this determination, an accurate sensor must be employed. Unfortunately, oxygen sensors implanted into the body have, thus far, typically required frequent and periodic checking and recalibration. In fact, one of the “holy grails” of the pacemaker industry has been an accurate, no drift, no calibration oxygen sensor. Up until now, such a sensor has been unavailable.
  • An ideal solution to the diagnostic requirements of those with disease or disability, absent an outright cure, is a sensing apparatus that may be implanted into the body and that may remain in the body for extended periods of time without the need to reset or recalibrate the sensor. Regardless of the particular application for such a sensor system, in order to effect such a system, the associated sensor must remain accurate, exhibit low drift and require no recalibration for extended periods of time.
  • Thus, an ideal implantable sensing apparatus would provide for a sensing apparatus that may be inserted into a vein, artery or other part of a body while being unobtrusive, easy to insert and remove, yet accurate and reliable. Embodiments of the present invention provides such a system.
  • SUMMARY OF THE DISCLOSURE
  • Embodiments of the present invention relate to a sensing apparatus. A sensing apparatus includes a cable having a first end and a second end, a connector residing at the first end of the cable and a sensor module residing at the second end of the cable. The cable, the connector and the sensor module may be unidiametrical.
  • The cable may comprise a core, a conductive element wrapped around the core, and a first tubing covering the core and the conductive element. The core may be polyester. The conductive element may be a ribbon cable. The conductive element may include wires. The wires may be platinum. The wires may be welded to the connector and the sensor module. Alternatively, the wires may be crimped to the connector. The first tubing of the cable may be radio opaque. A second tubing may cover the first tubing. A window may be cut into the second tubing.
  • The sensor module may have a first end and a second end. Beads may encapsulate the first end and the second end. The sensor module may also have a spacing element. A height of the spacing element may be greater than a height of the beads.
  • The sensing apparatus may also include an enzyme. The enzyme may be glucose oxidase or human serum albumin. The enzyme may be a protein matrix. The enzyme may be hydrated.
  • A method of making a sensing apparatus may comprise obtaining a connector; obtaining a cable; obtaining a sensor module; attaching a first end of the cable to the connector; and attaching a second end of the cable to the sensor module. The method may further include forming beads over ends of the sensor module; inserting a spacing element between the beads; covering the sensor module with a tubing of the cable; cutting a window in the tubing of the cable; and inserting an enzyme in the sensor module.
  • These and other objects, features, and advantages of embodiments of the invention will be apparent to those skilled in the art from the following detailed description of embodiments of the invention when read with the drawings and appended claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a generalized sensing apparatus configuration according to an embodiment of the present invention.
  • FIG. 2A is a perspective view of an electrode side of a generalized sensor module configuration according to an embodiment of the present invention.
  • FIG. 2B is a perspective view of an electronics side of a generalized sensor module configuration according to an embodiment of the present invention.
  • FIG. 3A is a perspective view of an electrode side of a generalized sensor module configuration with encapsulated ends according to an embodiment of the present invention.
  • FIG. 3B is a perspective view of an electronics side of a generalized sensor module configuration with encapsulated ends according to an embodiment of the present invention.
  • FIG. 4 is a perspective view of a sensor module configuration wherein two sensor modules are connected together in a “daisy-chain” fashion according to an embodiment of the present invention.
  • FIG. 5 is a perspective view of a sensor module with spacers according to an embodiment of the present invention.
  • FIG. 6A is a perspective view of a generalized sensor lead according to an embodiment of the present invention.
  • FIG. 6B is a perspective view of a conductor element according to an embodiment of the present invention.
  • FIG. 7 is a process for making a sensing apparatus according to an embodiment of the present invention.
  • FIG. 8 is a side showing a window cut into an outer tubing of the sensor. lead according to an embodiment of the present invention.
  • FIG. 9 is a process for removing or replacing a sensing apparatus according to an embodiment of the present invention.
  • DETAILED DESCRIPTION
  • In the following description of preferred embodiments, reference is made to the accompanying drawings which form a part hereof, and in which are shown by way of illustration specific embodiments in which the invention may be practiced. It is to be understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the preferred embodiments of the present invention.
  • Embodiments of the present invention comprise a sensing apparatus including, without limitation, a sensor module, a sensor lead and a connector. As will be explained below in greater detail, the sensor module may comprise, without limitation, an enzyme and one or more spacers. The lead may comprise, without limitation, a core, a conductor, a first tubing and a second tubing. In embodiments of the sensing apparatus, each element of the sensing apparatus may be modified separately or in conjunction with another element according to the application or environment in which sensing apparatus is used. Thus, the sensing apparatus may be seen as .a plurality of modular, individual elements, each of which may be modified and combined with one another to provide a sensing apparatus that may be used in a variety of applications, in a variety of environments, and implanted in a variety of locations.
  • FIG. 1 shows a generalized sensing apparatus configuration according to an embodiment of the present invention. A sensing apparatus 10 includes a sensor lead 12, a first end 14 comprising a connector 16 and a second end 18 comprising a sensor module 20. Molded onto each end of the sensor module 20 are beads 22. An ogive, or bullet shaped, tip 24 attaches to a bead 22 that is opposite the sensor lead 12 such that the entire assembly is streamlined in a fluidic environment, such as a bloodstream. The sensor lead 12 comprises tubing that attaches to the ogive tip 24. The entire sensing apparatus 10 may be placed in a vein or other area within a human body using a process according to an embodiment of the present invention to be discussed below.
  • The connector 16 may be a male, female or other type connector. The connector 16 may provide for multiple conductive paths, thereby accommodating a variety of sensor lead 12 configurations. Also, the connector 16 may be made from a variety of materials. For example, the connector 16 may be made from any material that is electrically conductive yet chemically inert.
  • FIGS. 2A and 2B show a generalized sensor configuration according to an embodiment of the present invention. A sensor module 20 may include a substrate 30 having a sensing element side 32 and an electronics side 34. The substrate 30 may be made from ceramic or other materials. As can be seen in FIG. 2A, electrodes 36 may be deposited onto the sensing element side 32 of the substrate 30. The electrodes 36 may interface with a sensing element (not shown) which will be described below. As can be seen in FIG. 2B, the electronics side 34 of the substrate 30 may include a lid 38 that covers a variety of electronics, such as, for example, an integrated circuit 40 and a capacitor 42. The electronics side 34 of the substrate 30 may also include welding pads 44 to which wire leads may be welded as well as other types of pads and traces common to electronic circuitry. The electrodes 36 and the electronics on the electronics side 34 of the substrate 30 provide the basis for electrochemical measurement. According to one embodiment of the invention, the sensor module 20 may be utilized for oxygen sensing. However, the sensor module is not limited to this application and may also be utilized in other applications such as, for example, for ion, neurotransmitter or nitric oxide sensing.
  • FIGS. 3A and 3B show further details of a generalized sensor configuration according to an embodiment of the present invention. In FIG. 3A, a portion of the electrode pattern may be encapsulated by the beads 22. In FIG. 3B, beads 22 may be molded over the ends of the substrate 30 such that the welding pads 44 and any wires welded to the welding pads 44 are encapsulated within the beads 22. In addition, the beads 22 may also encapsulate a core of the sensor lead 12, thereby giving the core an anchor. The beads 22 may be formed over the ends of the substrate 30 using a mold. The substrate 30 may be placed into the mold and the ends of the substrate 30 subsequently covered with an epoxy or other encapsulating material.
  • FIG. 4 shows a sensor configuration wherein two sensor modules 20 are connected together in a “daisy-chain” fashion. In this configuration, the welding pads 44 may be straight-through pads, such that electrical continuity exists between corresponding welding pads 44 on opposite sides of each sensor module 20. Thus, by serially connecting a welding pad 44 of one sensor module 20 to a corresponding welding pad 44 of another sensing module 20, the sensing modules 20 may be individually addressed using a two-wire line and unique addresses.
  • FIG. 5 shows a sensor module with spacers according to an embodiment of the present invention. A first spacing element 50 may be placed over the electrodes 36, fitting into a recess between the beads 22. The first spacing element 50 may be thought of as a spacer shim because it has the function of maintaining a certain distance or space between the electrodes 36 and an enzyme which may eventually be placed within the sensor module 20. The floor 52 of the first spacing element 50 may be such that it allows the passage of oxygen. If, for example, the first spacing element is made from silicone or polydimethylsiloxane, the floor 52 of the first spacing element 50 will pass oxygen but will not pass other compounds found in the bloodstream, such as glucose.
  • An enzyme and space may be used to fine tune sensor performance. The size and configuration of the enzyme and spacer may be modified to effect of variety of sensing characteristics. For example, the enzyme and spacer size and configuration may be modified to improve dynamic range, reduce noise due to oxygen transients, and increase sensing apparatus lifetime. The configuration of the enzyme and spacer may be driven by a variety of factors including, without limitation, the need to measure a physiological parameter, such as, for example, blood glucose, and the need to keep membranes of the sensor module 20 in compression during the lifetime of the device.
  • A second spacing element 54 fits within the first spacing element 50 and provides support for a window that may be cut into tubing that covers the sensor module 20 and attaches to the ogive tip 24. After the window has been cut, as will be explained below, the second spacing element 54 may be discarded and an enzyme or other sensing catalyst may be disposed in its place.
  • An outer tubing of the sensor lead 12 may be pulled over the first spacing element 50. The outer diameter of the first spacing element 50 may be such that it is greater than the inner diameter of the outer tubing of the sensor lead 12. Thus, when the outer tubing of the sensor lead 12 is pulled over the first spacing element 50 the first spacing element 50 may be forced against the electrodes 36 on the substrate 30 by the contraction force of the outer tubing.
  • The spacing elements may be made from the same mold used to form the beads 22. If the same mold that was used to form the beads 22 is used to form the spacing elements 50, 54, the spacing elements 50, 54 will form a precise fit with the beads 22. The spacing elements 50, 54 may be made from silicon or other suitable material.
  • In addition, the height of the first spacing element 50 may extend beyond the height of the beads 22. When the height of the first spacing element 50 and the beads 22 are offset, any compression upon the first spacing element 50, such as that that might be applied when the outer tubing of the sensor lead 12 is slipped over the sensor module 20, tends to stabilize the dimensions of the elements of the apparatus, such as membranes that may exist above the electrodes 36, that may change through chemical reaction.
  • FIG. 6A shows a generalized sensor lead 12 according to an embodiment of the present invention. At the center of the sensor lead 12 may be a core 60. The core 60 may be a material such as, for example, polyester or other material, or a commercially available material such as, for example, DACRON OR KEVLAR, that provides shock absorption and strength to the sensor lead 12. According to one embodiment of the present invention, a polyester core may provide as much as 18-20 lbs. of tensile strength to the sensor lead 20. In addition, the core 60 limits sensor lead 12 elongation. Thus, if the sensing apparatus 10 has been implanted into a vein in a human body, a doctor or other medical professional who needs to remove the sensing apparatus 10 from the vein may pull on the sensor lead 12 without fear of excessively stretching it or breaking it. Various factors may influence the size of the core 60 and the material used for the core 60 such as, for example, the overall diameter, device stiffness, and sensor lead 12 attachment scheme.
  • Wrapped around the core 60 in a helical fashion is a conductive element 62. The conductive element 62 may be a flat cable or ribbon cable having multiple conductor wires. The conductive element 62 may also be a laminate structure conducive to being wrapped around the core 60 with a pitch in between the windings such that the conductive element 62 has enough flexibility to move with the core 60 if the core 60 is stretched. The helical nature of the winding also contributes to the flexibility of the conductive element 62 if the core 60 is stretched or otherwise moved. The conductive element 62 may include only a few wires, such as, for example, three wires or four wires. Alternatively, if the application requires a large number of data channels or high current carrying capacitor, the conductive element 62 may include a larger number of wires, such as, for example, five wires, ten wires or more. The size of the conductive element 62, the number of wires in the conductive element 62, and the materials used as the conductive element 62 may be influenced by a variety of factors including, without limitation, sensing apparatus application and signal transmission requirements. For example, the size of the conductive element 62, the number of wires in the conductive element 62, and the materials used as the conductive element 62 may be chosen depending on whether the sensing apparatus is used in digital or analog applications or depending on a particular communications protocol. The strength of the conductive element 62 needed for a particular application may be a factor in determining wire size. In addition, the wires used in the conductive element 62 may be, for example, platinum, iridium, MP35, gold or silver, or other conductive material.
  • A first tubing 64 may be slid around the core 60 wrapped with the conductive element 60. The first tubing 64 may be made from a radio opaque material such as silicone or may be made from other materials such as, for example, radio opaque polyurethane. The size and dimensions of the first tubing 64 and the materials used for the first tubing 64 may be influenced by a variety of factors including, without limitation, the overall stiffness requirements of the sensor lead 12 according to the application of the sensing apparatus 10.
  • A second tubing 66 may be slid around the first tubing 64. The second tubing 66 may be made from silicone or other material. The second tubing 66 may be used to provide oxygen transport and mechanical compression. Depending on the application, the surface of the second tubing 66 may be treated for biocompatibility, lubricity and stiffness.
  • According to an embodiment of the present invention the conductive element 62 may be a flat cable having four wires 68 as shown in FIG. 6B. The wires 68 may be platinum or another type of conductor, such as, for example, a noble metal. The diameter of each wire 68 may be as thin as one one-thousandth of an inch or thinner and the entire cable may be molded with TEFLON or another insulator such that the wires are insulated from one another. Because much of the strength of the sensor lead 12 may be derived from the core 60, the wires themselves need not be chosen for strength. Thus, the wires need a diameter only as large as necessary to carry the currents being generated by the devices to which the sensor lead 12 is attached. For example, in the case where the sensor module 20 employs an electrochemical sensing element, the currents generated may be on the order of hundreds of nanoamps or tens of microamps. The type of wire used in the sensor lead 12 may be chosen accordingly. In the case where the sensor lead 12 is attached to a pacemaker, the wires may be chosen such that they can accommodate a current of a few milliamps, a typical value for heart stimulating pulses used in pacemakers. Thus, in the case where the sensor lead 12 is inserted into a vein, a metal such as platinum may be used as the wire. Platinum, although very fragile at the small diameters required for carrying the electrical currents just mentioned, such as, for example, one one-thousandth of an inch, is chemically inert and corrosion resistant and, thus, desirable in a fluidic environment, such as blood. However, because the wires are so thin, they may be generally less intrusive to the environment in which they are placed than larger diameter wires typically used in an in-vivo application. Thus, according to embodiments of the present invention, a thin, fragile wire may be used where, traditionally, larger diameter, strong wires have been used. Thus, a wire made from a metal such as platinum may be employed.
  • In order to connect the wires to the relevant portions of the connector 16 and the sensor module 20 the cable may be stripped and the wires connected together in groups of two. Once connected together, the wires may be viewed as two wires having two strands each. Thus, the wires are redundant and should one break, another is available to maintain electrical continuity. One of the wire pairs may then be crimped and welded to the connector 16 and the other wire pair may be spot welded to the wire pads 44 on the sensor module 20
  • A completed sensor lead 12 may be labeled for identification or other purposes. A variety of labeling materials may be used for labeling. According to one embodiment of the present invention, any labeling material may be used so long as the material chosen remains visible after sterilization of the sensing apparatus 10.
  • Also, the label may be placed in a variety of positions on the sensor lead 12. For example, according to one embodiment of the present invention, the label may be placed on the outer surface of the first tubing 64 in between the first tubing 64 and the second tubing 66 using an green-colored, epoxy based ink that is biocompatible and that does not leach toxic materials into or out of the sensor lead 12.
  • FIG. 7 shows a process for making a sensing apparatus according to an embodiment of the present invention. At step 70, the connector 16, the sensor lead 12 and the sensor module 20 are obtained. At step 72 the wires in the conductive element of the sensor lead 12 are attached to the pads 44 on the substrate 30 of the sensor module 20 and to the connector 16 The wires in the conductive element may be welded or otherwise attached to the pads 44 and crimped or otherwise attached to the connector.
  • At step 74, beads 22 are formed over the ends of the substrate 30 such that the welding pads, a portion of the electrodes 36 and the core 60 are encapsulated within the beads 22. In addition, an ogive tip 24 may be glued or otherwise attached to a bead 22 opposite the sensor lead 12.
  • At step 76 spacing elements may be inserted in between the beads 22. The spacers may comprise a first spacing element 50 and a second spacing element 54 At step 78, an outer tubing of the sensor lead 12 may be pulled over the sensor module 20 and attached to the ogive tip 24 attached to the bead 22 opposite the sensor lead 12.
  • At step 80, a window may be cut in the outer tubing of the sensor lead 12 over the second spacing element 54. The window may be cut and placed in a manner suitable for the application of the sensing apparatus 10 and such that the sensitivity of the apparatus is advantageous. For example, if the sensing apparatus is to be used in a glucose monitoring application, such as might be used in the case of a diabetic, the window may be cut with a particular width and at such a place on the outer tubing of the sensor lead 12 such that oxygen influx into the enzyme is aided. In glucose sensing applications, a typical window width may be five thousandths of an inch, or may be ten to twenty thousandths of an inch. In addition, window depth may be anywhere from about four thousandths of an inch to ten thousandths of an inch. The response time of the device may also be adjusted by the cut and placement of the window. A window 94 cut into an outer tubing of the sensor lead 12 may be seen in FIG. 8.
  • The second spacing element 54 may be removed at step 82 and the entire sensing apparatus 10 may be sterilized. The sterilization step 84 may be implemented using a variety of sterilization techniques. For example, the entire sensing apparatus 10 (which may or may not include an enzyme, protein, or other physiological parameter sensor) may be put into an ethylene oxide (ETO) gas such that the ETO gas permeates all of the elements of the sensing apparatus 10. After sterilization, the sensing apparatus may be stored until it is ready for use.
  • If desired, an enzyme may be put in the place of the second spacing element 54 through the window at step 86. The enzyme may be any of a variety of enzymes that may be employed for sensing. For example, if physiological parameter sensing is desired, one or more proteins may be used as the enzyme. According to one embodiment of the present invention, a combination of glucose oxidase and human serum albumin may be used concurrently in a solid matrix form to form a sensor matrix protein (SMP). The SMP may be cross-linked together or glymerized using glutaraldehyde or other suitable chemical such that a three-dimensional structure is created.
  • The enzyme may be hydrated at step 88 such that it expands to form a tight fit and to fill the area left by the removal of the second spacing element 54. The enzyme may initially be in a slightly desiccated state when placed into the area vacated by the second spacing element 54. Although such a desiccated state facilitates placement, space may exist between the enzyme and the surround area of the sensor module 20. Thus, the surrounding area and the enzyme may be hydrated with a sterile buffer, thereby swelling the enzyme and forming a compression fit with the first spacing element 50. Any cavity left in surrounding area after the enzyme has been hydrated may be filled at step 90 with, for example, a hydrogel, such as, for example, methacrylate or other hydrophilic acrylic, that is permeable to the sterilant. Subsequently, the hydrogel may be polymerized using a UV polymerization process.
  • At step 92, the window may be closed and the sensing apparatus 10 may be sterilized again in a manner that is not damaging to the enzyme. For example, a more dilute form of the glutaraldehyde may be used to sterilize the sensing apparatus 10 after the enzyme has been place in the first spacing element 50. The sensing apparatus 10 may then be used as necessary.
  • FIG. 9 shows a process for removing or replacing a sensing apparatus from a vein or artery. The vein or artery may belong to a human being or other animal. At step 100, a connector 16 that has been implanted into a vein along with the rest of the sensing apparatus is found by locating it under the skin by touch and feel in the general area that the connector 16 should be residing. At step 102, an incision is made into the skin and the connector 16 may be brought out of the skin.
  • At step 104, a tool with clamping fingers is placed over the connector 16 such that the fingers close onto the connector 16 and form a secure connection with the connector 16. A canula/introducer is then slid over the tool and the connector at step 106 into the vein at the location of the incision. Fabricating the connector 16, the sensor lead 12, and the sensor module 20 to be unidiametrical facilitates sliding the canula/introducer over them. While the canula/introducer remains in the vein, the tool, connector 16, sensor lead 12 and sensor module 20 may be pulled through the canula/introducer at step 108, thereby removing the sensing apparatus 10 from the vein.
  • At step 110, a new sensing apparatus may be inserted into the vein. Once the new sensing apparatus is inserted into the vein, the canula/introducer may be removed at step 112 and the incision may be sewn up.
  • While particular embodiments of the present invention have been shown and described, it will be obvious to those skilled in the art that the invention is not limited to the particular embodiments shown and described and that changes and modifications may be made without departing from the spirit and scope of the appended claims.

Claims (21)

1.-23. (canceled)
24. A sensing apparatus comprising a sensor module comprising:
a substrate having a first surface on which an electrode is provided;
a spacing element arranged adjacent the electrode, the spacing element having a catalyst receiving area for receiving an enzyme and maintaining the catalyst a defined distance from the electrode.
25. A sensing apparatus of claim 24, where the sensor module further comprises a pair of beads coupled to the substrate and spaced apart to define a recess between the beads, the spacing element being arranged in the recess between the beads.
26. A sensing apparatus of claim 24, further comprising:
an electrical connection pad on the substrate;
a cable having an electrical conductor connected to the electrical connection pad;
where one of the beads encapsulates the electrical connection pad.
27. A sensing apparatus of claim 26, where said one of the beads also encapsulates a portion of the cable.
28. A sensing apparatus of claim 26, where:
the cable has a connector and a length dimension; and
the electrical connection pad of the sensor module is connected to the cable at a location that is spaced apart from the connector such that the length dimension of the cable extends between the connector and the sensor module.
29. A sensing apparatus of claim 24, where the substrate has a first end and a second end and the sensor module further comprises:
a first electrical connection pad on the substrate, adjacent the first end of the substrate;
a second electrical connection pad on the substrate, adjacent the second end of the substrate;
a cable having an electrical conductor connected to one of the first or the second electrical connection pads;
a first bead on the first end of the substrate and encapsulating the first electrical connection pad; and
a second bead on the second end of the substrate and encapsulating the second electrical connection pad.
30. A sensing apparatus of claim 29, where the first and second beads are spaced apart to define a recess between the beads, the spacing element being arranged in the recess between the beads.
31. A sensing apparatus of claim 24, where the substrate has a first end and a second end and the sensor module further comprises:
a first pair of electrical connection pads on the substrate, adjacent the first end of the substrate;
a second pair of electrical connection pads on the substrate, adjacent the second end of the substrate;
a cable having a pair of electrical conductors connected to one of the first or the second pair of electrical connection pads;
a first bead on the first end of the substrate and encapsulating the first pair of electrical connection pads; and
a second bead on the second end of the substrate and encapsulating the second pair of electrical connection pads.
32. A sensing apparatus of claim 24, where:
the spacing element has at least one portion that has an outer circumferential surface that extends outward from the substrate a distance further than the beads,
the sensing apparatus further comprises an outer tubing disposed over the sensor module, the outer tubing having an inner surface that presses against the at least one portion of the spacing element, and causes the spacing element to press against the substrate.
33. A sensing apparatus of claim 32, where the outer tubing has a window arranged adjacent the catalyst receiving area of the spacing element.
34. A method of making a sensing apparatus comprising making a sensing module comprising:
providing a substrate having a first surface on which an electrode is disposed;
supporting a spacing element adjacent the electrode, the spacing element having a catalyst receiving area for receiving an enzyme and maintaining the catalyst a defined distance from the electrode.
35. A method of claim 34, where making the sensor module further comprises coupling a pair of beads to the substrate in a spaced apart relation to define a recess between the beads, and arranging the spacing element in the recess between the beads.
36. A method of claim 35, further comprising:
providing an electrical connection pad on the substrate;
connecting a cable having an electrical conductor to the electrical connection pad; and
encapsulating the electrical connection pad with one of the beads.
37. A method of claim 36, further comprising encapsulating a portion of the cable with said one of the beads.
38. A method of claim 35, where the cable has a connector and a length dimension, and the method further comprises connecting the electrical connection pad of the sensor module to the cable at a location that is spaced apart from the connector such that the length dimension of the cable extends between the connector and the sensor module.
39. A method of claim 34, where the substrate has a first end and a second end and the method of making the sensor module further comprises:
providing a first electrical connection pad on the substrate, adjacent the first end of the substrate;
providing a second electrical connection pad on the substrate, adjacent the second end of the substrate;
connecting a cable having an electrical conductor to one of the first or the second electrical connection pads;
encapsulating the first electrical connection pad with a first bead on the first end of the substrate; and
encapsulating the second electrical connection pad with a second bead on the second end of the substrate.
40. A method of claim 39, where the first and second beads are spaced apart to define a recess between the beads, the method further comprising arranging the spacing element in the recess between the beads.
41. A method of claim 34, where the substrate has a first end and a second end and the method of making the sensor module further comprises:
providing a first pair of electrical connection pads on the substrate, adjacent the first end of the substrate;
providing a second pair of electrical connection pads on the substrate, adjacent the second end of the substrate;
connecting a cable having a pair of electrical conductors to one of the first or the second pair of electrical connection pads;
encapsulating the first pair of electrical connection pads with a first bead on the first end of the substrate; and
encapsulating the second pair of electrical connection pads with a second bead on the second end of the substrate.
42. A method of claim 34, where:
the spacing element has at least one portion that has an outer circumferential surface that extends outward from the substrate a distance further than the beads,
the method of making the sensing apparatus further comprises disposing an outer tubing over the sensor module, the outer tubing having an inner surface that presses against the at least one portion of the spacing element, and causes the spacing element to press against the substrate.
43. A method of claim 42, further comprising providing the outer tubing with a window and arranging the window adjacent the catalyst receiving area of the spacing element.
US12/862,690 2001-09-07 2010-08-24 Sensing apparatus and process Abandoned US20110203923A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/862,690 US20110203923A1 (en) 2001-09-07 2010-08-24 Sensing apparatus and process

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31806001P 2001-09-07 2001-09-07
US10/036,093 US6915147B2 (en) 2001-09-07 2001-12-28 Sensing apparatus and process
US10/881,955 US20040236201A1 (en) 2001-09-07 2004-06-29 Sensing apparatus and process
US12/862,690 US20110203923A1 (en) 2001-09-07 2010-08-24 Sensing apparatus and process

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/881,955 Division US20040236201A1 (en) 2001-09-07 2004-06-29 Sensing apparatus and process

Publications (1)

Publication Number Publication Date
US20110203923A1 true US20110203923A1 (en) 2011-08-25

Family

ID=26712780

Family Applications (4)

Application Number Title Priority Date Filing Date
US10/036,093 Expired - Lifetime US6915147B2 (en) 2001-09-07 2001-12-28 Sensing apparatus and process
US10/881,955 Abandoned US20040236201A1 (en) 2001-09-07 2004-06-29 Sensing apparatus and process
US12/862,690 Abandoned US20110203923A1 (en) 2001-09-07 2010-08-24 Sensing apparatus and process
US13/073,951 Abandoned US20110178381A1 (en) 2001-09-07 2011-03-28 Sensing apparatus and process

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/036,093 Expired - Lifetime US6915147B2 (en) 2001-09-07 2001-12-28 Sensing apparatus and process
US10/881,955 Abandoned US20040236201A1 (en) 2001-09-07 2004-06-29 Sensing apparatus and process

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/073,951 Abandoned US20110178381A1 (en) 2001-09-07 2011-03-28 Sensing apparatus and process

Country Status (9)

Country Link
US (4) US6915147B2 (en)
EP (1) EP1434514B1 (en)
JP (1) JP4350509B2 (en)
AT (1) ATE490717T1 (en)
AU (1) AU2002323576A1 (en)
CA (1) CA2459561C (en)
DE (1) DE60238545D1 (en)
DK (1) DK1434514T3 (en)
WO (1) WO2003022128A2 (en)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US7181261B2 (en) * 2000-05-15 2007-02-20 Silver James H Implantable, retrievable, thrombus minimizing sensors
US7769420B2 (en) * 2000-05-15 2010-08-03 Silver James H Sensors for detecting substances indicative of stroke, ischemia, or myocardial infarction
US8133698B2 (en) * 2000-05-15 2012-03-13 Silver James H Sensors for detecting substances indicative of stroke, ischemia, infection or inflammation
US7006858B2 (en) * 2000-05-15 2006-02-28 Silver James H Implantable, retrievable sensors and immunosensors
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
US20040221407A1 (en) * 2001-07-30 2004-11-11 Tennant Company Cleaning liquid dispensing system
US7247162B1 (en) 2002-01-14 2007-07-24 Edwards Lifesciences Corporation Direct access atherectomy devices
US8996090B2 (en) * 2002-06-03 2015-03-31 Exostat Medical, Inc. Noninvasive detection of a physiologic parameter within a body tissue of a patient
US7162289B2 (en) * 2002-09-27 2007-01-09 Medtronic Minimed, Inc. Method and apparatus for enhancing the integrity of an implantable sensor device
US7087017B2 (en) * 2002-10-31 2006-08-08 Medtronic, Inc. Atraumatic sensor lead assemblies
EP1578262A4 (en) 2002-12-31 2007-12-05 Therasense Inc Continuous glucose monitoring system and methods of use
US7136704B2 (en) * 2003-04-16 2006-11-14 Alfred E. Mann Foundation For Scientific Research Blood oxygen monitoring system and a lead therefor
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US7146202B2 (en) * 2003-06-16 2006-12-05 Isense Corporation Compound material analyte sensor
US7630747B2 (en) * 2003-09-09 2009-12-08 Keimar, Inc. Apparatus for ascertaining blood characteristics and probe for use therewith
US8086323B2 (en) * 2003-09-23 2011-12-27 Medtronic Minimed, Inc. Implantable multi-parameter sensing system and method
US8948836B2 (en) * 2003-12-26 2015-02-03 Medtronic Minimed, Inc. Implantable apparatus for sensing multiple parameters
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
EP1781164A1 (en) * 2004-08-10 2007-05-09 Novo Nordisk A/S A method of forming a sterilised sensor package and a sterilised sensor package
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US20070219563A1 (en) * 2006-03-17 2007-09-20 Voegele Aaron C Reprocessing indicator ink for medical instruments
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8613725B2 (en) 2007-04-30 2013-12-24 Medtronic Minimed, Inc. Reservoir systems and methods
US8323250B2 (en) 2007-04-30 2012-12-04 Medtronic Minimed, Inc. Adhesive patch systems and methods
US7959715B2 (en) 2007-04-30 2011-06-14 Medtronic Minimed, Inc. Systems and methods allowing for reservoir air bubble management
JP5102350B2 (en) 2007-04-30 2012-12-19 メドトロニック ミニメド インコーポレイテッド Reservoir filling / bubble management / infusion medium delivery system and method using the system
US8597243B2 (en) 2007-04-30 2013-12-03 Medtronic Minimed, Inc. Systems and methods allowing for reservoir air bubble management
US7963954B2 (en) 2007-04-30 2011-06-21 Medtronic Minimed, Inc. Automated filling systems and methods
US8434528B2 (en) 2007-04-30 2013-05-07 Medtronic Minimed, Inc. Systems and methods for reservoir filling
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9968742B2 (en) 2007-08-29 2018-05-15 Medtronic Minimed, Inc. Combined sensor and infusion set using separated sites
US20120046533A1 (en) 2007-08-29 2012-02-23 Medtronic Minimed, Inc. Combined sensor and infusion sets
US8000918B2 (en) * 2007-10-23 2011-08-16 Edwards Lifesciences Corporation Monitoring and compensating for temperature-related error in an electrochemical sensor
WO2009059203A1 (en) * 2007-11-02 2009-05-07 Edwards Lifesciences Corporation Analyte monitoring system having back-up power source for use in either transport of the system or primary power loss
US20090188811A1 (en) 2007-11-28 2009-07-30 Edwards Lifesciences Corporation Preparation and maintenance of sensors
US20090240121A1 (en) * 2008-03-21 2009-09-24 Nova Biomedical Corporation Intravascular sensor and insertion set combination
US20100010328A1 (en) * 2008-07-11 2010-01-14 Nguyen Harry D Probes and sensors for ascertaining blood characteristics and methods and devices for use therewith
US8900431B2 (en) 2008-08-27 2014-12-02 Edwards Lifesciences Corporation Analyte sensor
US20100057046A1 (en) * 2008-09-03 2010-03-04 Keimar, Inc Systems for characterizing physiologic parameters and methods for use therewith
US8335551B2 (en) * 2008-09-29 2012-12-18 Chong Il Lee Method and means for connecting a large number of electrodes to a measuring device
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US9351677B2 (en) 2009-07-02 2016-05-31 Dexcom, Inc. Analyte sensor with increased reference capacity
US9237864B2 (en) 2009-07-02 2016-01-19 Dexcom, Inc. Analyte sensors and methods of manufacturing same
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc Analyte signal processing device and methods
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
US20110082356A1 (en) 2009-10-01 2011-04-07 Medtronic Minimed, Inc. Analyte sensor apparatuses having interference rejection membranes and methods for making and using them
US20110288388A1 (en) * 2009-11-20 2011-11-24 Medtronic Minimed, Inc. Multi-conductor lead configurations useful with medical device systems and methods for making and using them
US8660628B2 (en) 2009-12-21 2014-02-25 Medtronic Minimed, Inc. Analyte sensors comprising blended membrane compositions and methods for making and using them
US10448872B2 (en) 2010-03-16 2019-10-22 Medtronic Minimed, Inc. Analyte sensor apparatuses having improved electrode configurations and methods for making and using them
US9215995B2 (en) 2010-06-23 2015-12-22 Medtronic Minimed, Inc. Sensor systems having multiple probes and electrode arrays
US9008744B2 (en) 2011-05-06 2015-04-14 Medtronic Minimed, Inc. Method and apparatus for continuous analyte monitoring
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9493807B2 (en) 2012-05-25 2016-11-15 Medtronic Minimed, Inc. Foldover sensors and methods for making and using them
US20140012115A1 (en) 2012-07-03 2014-01-09 Medtronic Minimed, Inc. Plasma deposited adhesion promoter layers for use with analyte sensors
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US10194840B2 (en) 2012-12-06 2019-02-05 Medtronic Minimed, Inc. Microarray electrodes useful with analyte sensors and methods for making and using them
US10426383B2 (en) 2013-01-22 2019-10-01 Medtronic Minimed, Inc. Muting glucose sensor oxygen response and reducing electrode edge growth with pulsed current plating
US20150122647A1 (en) 2013-11-07 2015-05-07 Medtronic Minimed, Inc. Enzyme matrices for use with ethylene oxide sterilization
PL2982303T3 (en) 2014-08-06 2017-08-31 F. Hoffmann-La Roche Ag Medical device and method for producing a medical device
US10324058B2 (en) 2016-04-28 2019-06-18 Medtronic Minimed, Inc. In-situ chemistry stack for continuous glucose sensors
WO2017195035A1 (en) 2016-05-10 2017-11-16 Interface Biologics, Inc. Implantable glucose sensors having a biostable surface
US11298059B2 (en) 2016-05-13 2022-04-12 PercuSense, Inc. Analyte sensor
US11179078B2 (en) 2016-06-06 2021-11-23 Medtronic Minimed, Inc. Polycarbonate urea/urethane polymers for use with analyte sensors
US11134868B2 (en) 2017-03-17 2021-10-05 Medtronic Minimed, Inc. Metal pillar device structures and methods for making and using them in electrochemical and/or electrocatalytic applications
US10856784B2 (en) 2017-06-30 2020-12-08 Medtronic Minimed, Inc. Sensor initialization methods for faster body sensor response
US20190223771A1 (en) 2018-01-23 2019-07-25 Medtronic Minimed, Inc. Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses
US11186859B2 (en) 2018-02-07 2021-11-30 Medtronic Minimed, Inc. Multilayer electrochemical analyte sensors and methods for making and using them
US11583213B2 (en) 2018-02-08 2023-02-21 Medtronic Minimed, Inc. Glucose sensor electrode design
US11220735B2 (en) 2018-02-08 2022-01-11 Medtronic Minimed, Inc. Methods for controlling physical vapor deposition metal film adhesion to substrates and surfaces
CA3100384A1 (en) 2018-05-16 2019-11-21 Medtronic Minimed, Inc. Thermally stable glucose limiting membrane for glucose sensors
US11718865B2 (en) 2019-07-26 2023-08-08 Medtronic Minimed, Inc. Methods to improve oxygen delivery to implantable sensors
US11523757B2 (en) 2019-08-01 2022-12-13 Medtronic Minimed, Inc. Micro-pillar working electrodes design to reduce backflow of hydrogen peroxide in glucose sensor
CN115038381A (en) * 2020-01-03 2022-09-09 美国雅培糖尿病护理公司 Sensor array system and method for detecting multiple analytes
US20220031205A1 (en) 2020-07-31 2022-02-03 Medtronic Minimed, Inc. Sensor identification and integrity check design
US20220133190A1 (en) 2020-10-29 2022-05-05 Medtronic Minimed, Inc. Glucose biosensors comprising direct electron transfer enzymes and methods of making and using them
US20220240823A1 (en) 2021-01-29 2022-08-04 Medtronic Minimed, Inc. Interference rejection membranes useful with analyte sensors
US20220338768A1 (en) 2021-04-09 2022-10-27 Medtronic Minimed, Inc. Hexamethyldisiloxane membranes for analyte sensors
US20230053254A1 (en) 2021-08-13 2023-02-16 Medtronic Minimed, Inc. Dry electrochemical impedance spectroscopy metrology for conductive chemical layers
US20230113175A1 (en) 2021-10-08 2023-04-13 Medtronic Minimed, Inc. Immunosuppressant releasing coatings
US20230123613A1 (en) 2021-10-14 2023-04-20 Medtronic Minimed, Inc. Sensors for 3-hydroxybutyrate detection
US20230172497A1 (en) 2021-12-02 2023-06-08 Medtronic Minimed, Inc. Ketone limiting membrane and dual layer membrane approach for ketone sensing
US20240023849A1 (en) 2022-07-20 2024-01-25 Medtronic Minimed, Inc. Acrylate hydrogel membrane for dual function of diffusion limiting membrane as well as attenuation to the foreign body response

Citations (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240438A (en) * 1978-10-02 1980-12-23 Wisconsin Alumni Research Foundation Method for monitoring blood glucose levels and elements
US4246096A (en) * 1978-03-11 1981-01-20 Falconbridge Copper Limited Flotation process
US4266380A (en) * 1979-02-09 1981-05-12 Christy Concrete Products, Inc. High strength cover for underground utility box
US4479796A (en) * 1982-11-15 1984-10-30 Medtronic, Inc. Self-regenerating drug administration device
US4484987A (en) * 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4568335A (en) * 1981-08-28 1986-02-04 Markwell Medical Institute, Inc. Device for the controlled infusion of medications
US4628928A (en) * 1982-08-09 1986-12-16 Medtronic, Inc. Robotic implantable medical device and/or component restoration system
US4650547A (en) * 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4672970A (en) * 1984-07-30 1987-06-16 Mitsubishi Rayon Company, Ltd. Electrode for living body
US4703756A (en) * 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4757022A (en) * 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
US4771772A (en) * 1982-08-09 1988-09-20 Medtronic, Inc. Robotic implantable medical device and/or component restoration system
US4807629A (en) * 1986-08-15 1989-02-28 Medtronic, Inc. Oxygen sensing pacemaker
US4865038A (en) * 1986-10-09 1989-09-12 Novametrix Medical Systems, Inc. Sensor appliance for non-invasive monitoring
US4867557A (en) * 1987-04-09 1989-09-19 Sumitomo Electric Industries, Ltd. Reflection type oximeter for applying light pulses to a body tissue to measure oxygen saturation
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4957110A (en) * 1989-03-17 1990-09-18 C. R. Bard, Inc. Steerable guidewire having electrodes for measuring vessel cross-section and blood flow
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US5094951A (en) * 1988-06-21 1992-03-10 Chiron Corporation Production of glucose oxidase in recombinant systems
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5266688A (en) * 1988-06-21 1993-11-30 Chiron Corporation Polynucleotide sequence for production of glucose oxidase in recombinant systems
US5298682A (en) * 1992-08-20 1994-03-29 Wireworld By David Salz, Inc. Optimized symmetrical coaxial cable
US5304219A (en) * 1991-06-14 1994-04-19 Siemens Pacesetter, Inc. Multipolar in-line proximal connector assembly for an implantable stimulation device
US5313020A (en) * 1992-05-29 1994-05-17 Western Atlas International, Inc. Electrical cable
US5328460A (en) * 1991-06-21 1994-07-12 Pacesetter Infusion, Ltd. Implantable medication infusion pump including self-contained acoustic fault detection apparatus
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5500488A (en) * 1993-07-22 1996-03-19 Buckel; Konrad Wide band high frequency compatible electrical coaxial cable
US5534025A (en) * 1993-06-08 1996-07-09 The Governors Of The University Of Alberta Vascular bioartificial organ
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5667983A (en) * 1994-10-24 1997-09-16 Chiron Diagnostics Corporation Reagents with enhanced performance in clinical diagnostic systems
US5696314A (en) * 1996-07-12 1997-12-09 Chiron Diagnostics Corporation Multilayer enzyme electrode membranes and methods of making same
US5707502A (en) * 1996-07-12 1998-01-13 Chiron Diagnostics Corporation Sensors for measuring analyte concentrations and methods of making same
US5711868A (en) * 1994-06-27 1998-01-27 Chiron Diagnostics Corporatiion Electrochemical sensors membrane
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5741319A (en) * 1995-01-27 1998-04-21 Medtronic, Inc. Biocompatible medical lead
US5743261A (en) * 1993-12-06 1998-04-28 Sensor Devices, Inc. Methods and apparatus for the invasive use of oximeter probes
US5745627A (en) * 1995-12-28 1998-04-28 Lucent Technologies Inc. Composite cable for fiber-to-the-curb architecture using centralized power
US5773270A (en) * 1991-03-12 1998-06-30 Chiron Diagnostics Corporation Three-layered membrane for use in an electrochemical sensor system
US5791344A (en) * 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5804048A (en) * 1996-08-15 1998-09-08 Via Medical Corporation Electrode assembly for assaying glucose
US5919216A (en) * 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
US5932175A (en) * 1996-09-25 1999-08-03 Via Medical Corporation Sensor apparatus for use in measuring a parameter of a fluid sample
US5941906A (en) * 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
US5985129A (en) * 1989-12-14 1999-11-16 The Regents Of The University Of California Method for increasing the service life of an implantable sensor
US5992211A (en) * 1998-04-23 1999-11-30 Medtronic, Inc. Calibrated medical sensing catheter system
US6002954A (en) * 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US6001067A (en) * 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6019729A (en) * 1996-11-15 2000-02-01 Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho Sensor mechanism-equipped catheter
US6027479A (en) * 1998-02-27 2000-02-22 Via Medical Corporation Medical apparatus incorporating pressurized supply of storage liquid
US6049727A (en) * 1996-07-08 2000-04-11 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
US6081736A (en) * 1997-10-20 2000-06-27 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems adapted for long term use
US6093167A (en) * 1997-06-16 2000-07-25 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6103033A (en) * 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US6122536A (en) * 1995-07-06 2000-09-19 Animas Corporation Implantable sensor and system for measurement and control of blood constituent levels
US6120676A (en) * 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US6125290A (en) * 1998-10-30 2000-09-26 Medtronic, Inc. Tissue overgrowth detector for implantable medical device
US6125291A (en) * 1998-10-30 2000-09-26 Medtronic, Inc. Light barrier for medical electrical lead oxygen sensor
US6134459A (en) * 1998-10-30 2000-10-17 Medtronic, Inc. Light focusing apparatus for medical electrical lead oxygen sensor
US6140587A (en) * 1997-05-20 2000-10-31 Shaw Industries, Ltd. Twin axial electrical cable
US6143150A (en) * 1996-07-03 2000-11-07 Nihon Kohden Corporation Biological gas sensor
US6144866A (en) * 1998-10-30 2000-11-07 Medtronic, Inc. Multiple sensor assembly for medical electric lead
US6159240A (en) * 1998-08-31 2000-12-12 Medtronic, Inc. Rigid annuloplasty device that becomes compliant after implantation
US6163723A (en) * 1998-10-22 2000-12-19 Medtronic, Inc. Circuit and method for implantable dual sensor medical electrical lead
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6198952B1 (en) * 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead
US6201980B1 (en) * 1998-10-05 2001-03-13 The Regents Of The University Of California Implantable medical sensor system
US6248067B1 (en) * 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same
US6248080B1 (en) * 1997-09-03 2001-06-19 Medtronic, Inc. Intracranial monitoring and therapy delivery control device, system and method
US6251260B1 (en) * 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US6259937B1 (en) * 1997-09-12 2001-07-10 Alfred E. Mann Foundation Implantable substrate sensor
US6466810B1 (en) * 1995-11-22 2002-10-15 Legacy Good Samaritan Hospital And Medical Center Implantable device for monitoring changes in analyte concentration

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1598764A1 (en) * 1965-08-30 1970-06-18 Carus Carl Gustav Device for the adjustable tightening of the membrane of a microneedle measuring chain, preferably used for electrochemical oxygen measurement in very small measuring objects, and a method for better handling of the electrolyte and for fixing the membrane
US4911168A (en) 1989-01-13 1990-03-27 Pacesetter Infusion, Ltd. Method of screening and selecting intraperitoneal medication infusion pump candidates
SE9504233D0 (en) 1995-11-27 1995-11-27 Pacesetter Ab Implantable medical device
US6516808B2 (en) * 1997-09-12 2003-02-11 Alfred E. Mann Foundation For Scientific Research Hermetic feedthrough for an implantable device
WO1999017095A1 (en) 1997-09-30 1999-04-08 M-Biotech, Inc. Biosensor
US6078830A (en) * 1997-10-01 2000-06-20 Ep Technologies, Inc. Molded catheter distal end assembly and process for the manufacture thereof
US6097976A (en) * 1998-02-27 2000-08-01 Ep Technologies, Inc. Catheter distal end assemblies with bonded surface coatings
US6261280B1 (en) 1999-03-22 2001-07-17 Medtronic, Inc Method of obtaining a measure of blood glucose
US6317615B1 (en) * 1999-04-19 2001-11-13 Cardiac Pacemakers, Inc. Method and system for reducing arterial restenosis in the presence of an intravascular stent
USD426638S (en) 1999-05-06 2000-06-13 Therasense, Inc. Glucose sensor buttons
USD424696S (en) 1999-05-06 2000-05-09 Therasense, Inc. Glucose sensor
US6368274B1 (en) 1999-07-01 2002-04-09 Medtronic Minimed, Inc. Reusable analyte sensor site and method of using the same
EP1080684A3 (en) * 1999-09-03 2003-04-16 Nihon Kohden Corporation Sensor for measuring a gas or ion concentration in living tissue
US6295476B1 (en) * 1999-11-01 2001-09-25 Medtronic, Inc. Medical lead conductor fracture visualization method and apparatus
US6446810B1 (en) * 2000-12-18 2002-09-10 Durabag Co., Inc. Tabless self-opening bag pack
US6671554B2 (en) * 2001-09-07 2003-12-30 Medtronic Minimed, Inc. Electronic lead for a medical implant device, method of making same, and method and apparatus for inserting same

Patent Citations (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4246096A (en) * 1978-03-11 1981-01-20 Falconbridge Copper Limited Flotation process
US4240438A (en) * 1978-10-02 1980-12-23 Wisconsin Alumni Research Foundation Method for monitoring blood glucose levels and elements
US4266380A (en) * 1979-02-09 1981-05-12 Christy Concrete Products, Inc. High strength cover for underground utility box
US4568335A (en) * 1981-08-28 1986-02-04 Markwell Medical Institute, Inc. Device for the controlled infusion of medications
US4771772A (en) * 1982-08-09 1988-09-20 Medtronic, Inc. Robotic implantable medical device and/or component restoration system
US4628928A (en) * 1982-08-09 1986-12-16 Medtronic, Inc. Robotic implantable medical device and/or component restoration system
US4479796A (en) * 1982-11-15 1984-10-30 Medtronic, Inc. Self-regenerating drug administration device
US4484987A (en) * 1983-05-19 1984-11-27 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4650547A (en) * 1983-05-19 1987-03-17 The Regents Of The University Of California Method and membrane applicable to implantable sensor
US4672970A (en) * 1984-07-30 1987-06-16 Mitsubishi Rayon Company, Ltd. Electrode for living body
US4890620A (en) * 1985-09-20 1990-01-02 The Regents Of The University Of California Two-dimensional diffusion glucose substrate sensing electrode
US4757022A (en) * 1986-04-15 1988-07-12 Markwell Medical Institute, Inc. Biological fluid measuring device
US4994167A (en) * 1986-04-15 1991-02-19 Markwell Medical Institute, Inc. Biological fluid measuring device
US4703756A (en) * 1986-05-06 1987-11-03 The Regents Of The University Of California Complete glucose monitoring system with an implantable, telemetered sensor module
US4807629A (en) * 1986-08-15 1989-02-28 Medtronic, Inc. Oxygen sensing pacemaker
US4865038A (en) * 1986-10-09 1989-09-12 Novametrix Medical Systems, Inc. Sensor appliance for non-invasive monitoring
US4867557A (en) * 1987-04-09 1989-09-19 Sumitomo Electric Industries, Ltd. Reflection type oximeter for applying light pulses to a body tissue to measure oxygen saturation
US5094951A (en) * 1988-06-21 1992-03-10 Chiron Corporation Production of glucose oxidase in recombinant systems
US5266688A (en) * 1988-06-21 1993-11-30 Chiron Corporation Polynucleotide sequence for production of glucose oxidase in recombinant systems
US4957110A (en) * 1989-03-17 1990-09-18 C. R. Bard, Inc. Steerable guidewire having electrodes for measuring vessel cross-section and blood flow
US5985129A (en) * 1989-12-14 1999-11-16 The Regents Of The University Of California Method for increasing the service life of an implantable sensor
US5165407A (en) * 1990-04-19 1992-11-24 The University Of Kansas Implantable glucose sensor
US5773270A (en) * 1991-03-12 1998-06-30 Chiron Diagnostics Corporation Three-layered membrane for use in an electrochemical sensor system
US5304219A (en) * 1991-06-14 1994-04-19 Siemens Pacesetter, Inc. Multipolar in-line proximal connector assembly for an implantable stimulation device
US5328460A (en) * 1991-06-21 1994-07-12 Pacesetter Infusion, Ltd. Implantable medication infusion pump including self-contained acoustic fault detection apparatus
US5313020A (en) * 1992-05-29 1994-05-17 Western Atlas International, Inc. Electrical cable
US5298682A (en) * 1992-08-20 1994-03-29 Wireworld By David Salz, Inc. Optimized symmetrical coaxial cable
US5534025A (en) * 1993-06-08 1996-07-09 The Governors Of The University Of Alberta Vascular bioartificial organ
US5500488A (en) * 1993-07-22 1996-03-19 Buckel; Konrad Wide band high frequency compatible electrical coaxial cable
US5660163A (en) * 1993-11-19 1997-08-26 Alfred E. Mann Foundation For Scientific Research Glucose sensor assembly
US5791344A (en) * 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5497772A (en) * 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US6162611A (en) * 1993-12-02 2000-12-19 E. Heller & Company Subcutaneous glucose electrode
US5593852A (en) * 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
US5965380A (en) * 1993-12-02 1999-10-12 E. Heller & Company Subcutaneous glucose electrode
US5743261A (en) * 1993-12-06 1998-04-28 Sensor Devices, Inc. Methods and apparatus for the invasive use of oximeter probes
US5770028A (en) * 1994-06-27 1998-06-23 Chiron Diagnostics Corporation Glucose and lactate sensors
US5711868A (en) * 1994-06-27 1998-01-27 Chiron Diagnostics Corporatiion Electrochemical sensors membrane
US5667983A (en) * 1994-10-24 1997-09-16 Chiron Diagnostics Corporation Reagents with enhanced performance in clinical diagnostic systems
US5741319A (en) * 1995-01-27 1998-04-21 Medtronic, Inc. Biocompatible medical lead
US6122536A (en) * 1995-07-06 2000-09-19 Animas Corporation Implantable sensor and system for measurement and control of blood constituent levels
US5741211A (en) * 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US6466810B1 (en) * 1995-11-22 2002-10-15 Legacy Good Samaritan Hospital And Medical Center Implantable device for monitoring changes in analyte concentration
US6002954A (en) * 1995-11-22 1999-12-14 The Regents Of The University Of California Detection of biological molecules using boronate-based chemical amplification and optical sensors
US5745627A (en) * 1995-12-28 1998-04-28 Lucent Technologies Inc. Composite cable for fiber-to-the-curb architecture using centralized power
US6143150A (en) * 1996-07-03 2000-11-07 Nihon Kohden Corporation Biological gas sensor
US6049727A (en) * 1996-07-08 2000-04-11 Animas Corporation Implantable sensor and system for in vivo measurement and control of fluid constituent levels
US5696314A (en) * 1996-07-12 1997-12-09 Chiron Diagnostics Corporation Multilayer enzyme electrode membranes and methods of making same
US5707502A (en) * 1996-07-12 1998-01-13 Chiron Diagnostics Corporation Sensors for measuring analyte concentrations and methods of making same
US5804048A (en) * 1996-08-15 1998-09-08 Via Medical Corporation Electrode assembly for assaying glucose
US5932175A (en) * 1996-09-25 1999-08-03 Via Medical Corporation Sensor apparatus for use in measuring a parameter of a fluid sample
US6019729A (en) * 1996-11-15 2000-02-01 Kabushiki Kaisha Tokai-Rika-Denki-Seisakusho Sensor mechanism-equipped catheter
US6120676A (en) * 1997-02-06 2000-09-19 Therasense, Inc. Method of using a small volume in vitro analyte sensor
US6001067A (en) * 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US6140587A (en) * 1997-05-20 2000-10-31 Shaw Industries, Ltd. Twin axial electrical cable
US6093167A (en) * 1997-06-16 2000-07-25 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US5919216A (en) * 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
US6135978A (en) * 1997-06-16 2000-10-24 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6248080B1 (en) * 1997-09-03 2001-06-19 Medtronic, Inc. Intracranial monitoring and therapy delivery control device, system and method
US6259937B1 (en) * 1997-09-12 2001-07-10 Alfred E. Mann Foundation Implantable substrate sensor
US5941906A (en) * 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
US6081736A (en) * 1997-10-20 2000-06-27 Alfred E. Mann Foundation Implantable enzyme-based monitoring systems adapted for long term use
US6027479A (en) * 1998-02-27 2000-02-22 Via Medical Corporation Medical apparatus incorporating pressurized supply of storage liquid
US6103033A (en) * 1998-03-04 2000-08-15 Therasense, Inc. Process for producing an electrochemical biosensor
US5992211A (en) * 1998-04-23 1999-11-30 Medtronic, Inc. Calibrated medical sensing catheter system
US6175752B1 (en) * 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US6251260B1 (en) * 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US6159240A (en) * 1998-08-31 2000-12-12 Medtronic, Inc. Rigid annuloplasty device that becomes compliant after implantation
US6201980B1 (en) * 1998-10-05 2001-03-13 The Regents Of The University Of California Implantable medical sensor system
US6163723A (en) * 1998-10-22 2000-12-19 Medtronic, Inc. Circuit and method for implantable dual sensor medical electrical lead
US6144866A (en) * 1998-10-30 2000-11-07 Medtronic, Inc. Multiple sensor assembly for medical electric lead
US6134459A (en) * 1998-10-30 2000-10-17 Medtronic, Inc. Light focusing apparatus for medical electrical lead oxygen sensor
US6198952B1 (en) * 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead
US6125291A (en) * 1998-10-30 2000-09-26 Medtronic, Inc. Light barrier for medical electrical lead oxygen sensor
US6125290A (en) * 1998-10-30 2000-09-26 Medtronic, Inc. Tissue overgrowth detector for implantable medical device
US6248067B1 (en) * 1999-02-05 2001-06-19 Minimed Inc. Analyte sensor and holter-type monitor system and method of using the same

Also Published As

Publication number Publication date
EP1434514B1 (en) 2010-12-08
JP2005501636A (en) 2005-01-20
EP1434514A2 (en) 2004-07-07
CA2459561A1 (en) 2003-03-20
ATE490717T1 (en) 2010-12-15
DE60238545D1 (en) 2011-01-20
US20110178381A1 (en) 2011-07-21
EP1434514A4 (en) 2008-02-20
JP4350509B2 (en) 2009-10-21
US20030050547A1 (en) 2003-03-13
WO2003022128A2 (en) 2003-03-20
DK1434514T3 (en) 2011-03-14
CA2459561C (en) 2012-11-06
AU2002323576A1 (en) 2003-03-24
US20040236201A1 (en) 2004-11-25
US6915147B2 (en) 2005-07-05
WO2003022128A3 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
US6915147B2 (en) Sensing apparatus and process
US6965791B1 (en) Implantable biosensor system, apparatus and method
JP4533145B2 (en) Integrity expansion method and apparatus for implantable sensor devices
EP1148808B1 (en) Holter-type monitor system comprising an analyte sensor
US4890623A (en) Biopotential sensing device and method for making
US6464849B1 (en) Sensor for measuring a bioanalyte such as lactate
US6520326B2 (en) Glucose sensor package system
CN102686159B (en) Multi-conductor lead configurations useful with medical device systems and methods for making and using them
US11510595B2 (en) Tubular sensor for the detection of an analyte
US20090270707A1 (en) Sensor Assemblies for Implantable Medical Electrical Leads
WO2019239258A1 (en) Flexible ultra low profile transcutaneous continuous monitoring sensor
EP1222455B1 (en) Sensor comprising an outer insulating layer comprising a plurality of electrically conductive fibers covered by a sensitive material on at least some of the fibres and voids between the fibres
CN217365861U (en) Electrochemical sensor
US20230079720A1 (en) Methods and Systems for Continuously Monitoring the Glucose Level of a Patient
JP2003111742A (en) Sensor for measuring biological information and method for manufacturing the same
JP2017074218A (en) Biological sensor, and continuous glucose monitoring (cgm) system
CA2580887A1 (en) Glucose sensor package system

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION